AstraZeneca (AZN) News Today $67.72 -1.23 (-1.78%) As of 05/13/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AZN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Cetera Investment Advisers Has $12.76 Million Position in AstraZeneca PLC (NASDAQ:AZN)Cetera Investment Advisers trimmed its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 2.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 194,746 shares of the company's stock after selMay 13 at 5:32 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Position Boosted by Ethic Inc.Ethic Inc. boosted its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 7.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 97,608 shares of the company's stock after buying an additional 6,475 sMay 12 at 5:52 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Fred Alger Management LLCFred Alger Management LLC trimmed its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 72.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 98,631 shares of the company's stock after selling 258,983 shares duMay 12 at 5:35 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Stake Raised by Clark Capital Management Group Inc.Clark Capital Management Group Inc. boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 89.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,047 shares of the company's stock after acquiring an adMay 12 at 5:35 AM | marketbeat.comEP Wealth Advisors LLC Purchases 7,802 Shares of AstraZeneca PLC (NASDAQ:AZN)EP Wealth Advisors LLC grew its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 38.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 28,238 shares of the company's stock after buying an additionalMay 12 at 5:18 AM | marketbeat.com55,922 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC bought a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 55,922 shares of the company's stock, valued at approximately $3,664,000. SMay 12 at 5:09 AM | marketbeat.comCary Street Partners Financial LLC Takes Position in AstraZeneca PLC (NASDAQ:AZN)Cary Street Partners Financial LLC bought a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 6,718 shares of the company's stock, valuedMay 12 at 4:34 AM | marketbeat.comEllevest Inc. Sells 5,080 Shares of AstraZeneca PLC (NASDAQ:AZN)Ellevest Inc. decreased its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 24.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,093 shares of the company's stock after selling 5,080 sharesMay 11 at 8:06 AM | marketbeat.comCaptrust Financial Advisors Has $7.84 Million Position in AstraZeneca PLC (NASDAQ:AZN)Captrust Financial Advisors lessened its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 12.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 119,690 shares of the company's stock after selling 17,443 shares during the quarterMay 11 at 5:43 AM | marketbeat.comBNP Paribas Financial Markets Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)BNP Paribas Financial Markets cut its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 9.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 466,716 shares of the company's stock after selling 49,269 shares durMay 11 at 4:59 AM | marketbeat.comCrestline Management LP Sells 23,934 Shares of AstraZeneca PLC (NASDAQ:AZN)Crestline Management LP reduced its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 39.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 37,335 shares of the company's stock after selling 23,934 shares during the period. Crestline ManagemenMay 10, 2025 | marketbeat.comAptus Capital Advisors LLC Boosts Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Aptus Capital Advisors LLC increased its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 143.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,342 shares of the company's stock after acquiring an adMay 10, 2025 | marketbeat.comIMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trialMay 9, 2025 | businesswire.comBaird Financial Group Inc. Boosts Position in AstraZeneca PLC (NASDAQ:AZN)Baird Financial Group Inc. grew its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 6.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 264,741 shares of the company's stock after acquiring an additional 15,723May 9, 2025 | marketbeat.comTempus AI Stock: Time to Double Down or Cut and Run? (AZN)Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential.May 8, 2025 | marketbeat.comCovenant Partners LLC Has $677,000 Position in AstraZeneca PLC (NASDAQ:AZN)Covenant Partners LLC decreased its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 25.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,340 shares of the company's stock after selling 3,585 shares during thMay 8, 2025 | marketbeat.comBalyasny Asset Management L.P. Has $42.83 Million Position in AstraZeneca PLC (NASDAQ:AZN)Balyasny Asset Management L.P. raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 2,613.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 653,668 shares of the company's stock after purchasingMay 8, 2025 | marketbeat.comBamco Inc. NY Sells 25,592 Shares of AstraZeneca PLC (NASDAQ:AZN)Bamco Inc. NY lowered its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 107,652 shares of the company's stock after selling 25,592 shares during the quarter. BamcoMay 8, 2025 | marketbeat.comBenjamin Edwards Inc. Has $3.67 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)Benjamin Edwards Inc. trimmed its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 6.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 56,075 shares of the company's stock after selling 3,796 shareMay 8, 2025 | marketbeat.comAmeriprise Financial Inc. Purchases 390,407 Shares of AstraZeneca PLC (NASDAQ:AZN)Ameriprise Financial Inc. lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 9.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,681,303 shares of the company's stock afteMay 8, 2025 | marketbeat.comDoes the GSK or AstraZeneca share price currently offer the best value?May 8, 2025 | msn.comAstraZeneca, Daiichi post late-stage trial win for Enhertu in early-stage breast cancerMay 7, 2025 | msn.comAstraZeneca (LSE:AZN) Reports Positive Phase 3 Trial Results For Breast Cancer TreatmentMay 7, 2025 | finance.yahoo.comBayesian Capital Management LP Takes $2.10 Million Position in AstraZeneca PLC (NASDAQ:AZN)Bayesian Capital Management LP acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 32,100 shares of the company'May 7, 2025 | marketbeat.comBank of America Corp DE Grows Stock Position in AstraZeneca PLC (NASDAQ:AZN)Bank of America Corp DE grew its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 189.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 24,026,966 shares of the company's stock after buying an additional 15,May 7, 2025 | marketbeat.comAlteri Wealth LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)Alteri Wealth LLC bought a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 3,919 shares of the company's stock, valued at approximateMay 7, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Increases Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Schonfeld Strategic Advisors LLC boosted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 74.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,300 shares of the company's stock afterMay 7, 2025 | marketbeat.comBearing Point Capital LLC Purchases New Stake in AstraZeneca PLC (NASDAQ:AZN)Bearing Point Capital LLC bought a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 11,407 shares of the company's stock, valuedMay 6, 2025 | marketbeat.comAxa S.A. Acquires 46,452 Shares of AstraZeneca PLC (NASDAQ:AZN)Axa S.A. lifted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 11.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 469,644 shares of the company's stock after purchasing an additional 46,452 shares during the period.May 6, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Invests $10.49 Million in AstraZeneca PLC (NASDAQ:AZN)Mercer Global Advisors Inc. ADV bought a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 160,124 shares of the company's stock, valued at approximately $10,49May 6, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Decreases Holdings in AstraZeneca PLC (NASDAQ:AZN)The Manufacturers Life Insurance Company lowered its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 197,125 shares ofMay 6, 2025 | marketbeat.comAlyeska Investment Group L.P. Purchases 2,083,645 Shares of AstraZeneca PLC (NASDAQ:AZN)Alyeska Investment Group L.P. lifted its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 220.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,027,511 shares of the company's stock after purchasing an additioMay 5, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Beacon Pointe Advisors LLCBeacon Pointe Advisors LLC cut its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 21.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,056 shares of the companyMay 4, 2025 | marketbeat.comAnalysts Set AstraZeneca PLC (NASDAQ:AZN) Price Target at $88.00May 4, 2025 | americanbankingnews.comAstraZeneca PLC (NASDAQ:AZN) Shares Bought by Itau Unibanco Holding S.A.Itau Unibanco Holding S.A. lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 74.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,361 shares of the company's stock after purchaMay 3, 2025 | marketbeat.comNorthern Trust Corp Buys 952,010 Shares of AstraZeneca PLC (NASDAQ:AZN)Northern Trust Corp grew its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 25.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,692,678 shares of the company's stock after acquiring an additionMay 3, 2025 | marketbeat.comTwo Sigma Securities LLC Trims Position in AstraZeneca PLC (NASDAQ:AZN)Two Sigma Securities LLC trimmed its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 98.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,167 shares of the company's stock after selling 167,048 shMay 3, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Buy" from AnalystsShares of AstraZeneca PLC (NASDAQ:AZN - Get Free Report) have been given an average recommendation of "Buy" by the ten brokerages that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and two hMay 3, 2025 | marketbeat.comGuardian Capital LP Acquires 4,497 Shares of AstraZeneca PLC (NASDAQ:AZN)Guardian Capital LP raised its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 58,951 shares of the company's stock after buying an additional 4,497 shares duMay 2, 2025 | marketbeat.comWick Capital Partners LLC Has $1.20 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)Wick Capital Partners LLC increased its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 128.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,360 shares of the company's stock after purchasingMay 2, 2025 | marketbeat.comQ1 EPS Estimates for AstraZeneca Raised by Leerink PartnrsAstraZeneca PLC (NASDAQ:AZN - Free Report) - Equities researchers at Leerink Partnrs raised their Q1 2025 earnings per share (EPS) estimates for AstraZeneca in a note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the company will earn $1.13 perMay 2, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Kovitz Investment Group Partners LLCKovitz Investment Group Partners LLC decreased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 33.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,799 shares of the comMay 2, 2025 | marketbeat.comAstraZeneca's Breztri meets main goals of late-stage asthma trialsMay 2, 2025 | reuters.comSoros Fund Management LLC Acquires 503,030 Shares of AstraZeneca PLC (NASDAQ:AZN)Soros Fund Management LLC lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,155,801 shares of the company's stock after acquiring an additional 503,030 shares during the perMay 1, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Sees Large Decrease in Short InterestAstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 6,330,000 shares, a decrease of 40.3% from the March 31st total of 10,600,000 shares. Currently, 0.2% of the company's stock are sold short. Based on an average trading volume of 6,020,000 shares, the short-interest ratio is currently 1.1 days.May 1, 2025 | marketbeat.comHsbc Holdings PLC Reduces Holdings in AstraZeneca PLC (NASDAQ:AZN)Hsbc Holdings PLC lessened its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 93.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 112,749 shares of the company's stock after selling 1,702,389 shares during the quarteMay 1, 2025 | marketbeat.comAstraZeneca’s share price is down 20% from September, so is it time for me to buy?May 1, 2025 | msn.comAstraZeneca Sales, Earnings Rise; Faces China Tax ProbeApril 30, 2025 | wsj.comAstraZeneca PLC (NASDAQ:AZN) Q1 2025 Earnings Call TranscriptApril 30, 2025 | msn.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 93.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,370 shares of the companApril 30, 2025 | marketbeat.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼1.420.82▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼2825▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenx News BioNTech News Beigene News Teva Pharmaceutical Industries News Summit Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredA New Economic Shift – How You Can PrepareWhile everyone's focused on the Fed and interest rates... most investors are missing the real story. There'...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredDrop these 5 stocks now!You think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts